Curcumin (Cur) has anticancer activities but has poor stability, which can be improved using
carrier materials. In this study, chitosan was aminated to increase the number of amino …

Multi-drug chemotherapy has been one of the most popular strategies for the treatment of
malignant tumors, and has achieved desirable therapeutic outcomes. The objective of the …

Curcumin (CUR) is an emerging natural agent for cancer therapy. However, the low
therapeutic efficacy and weak selectivity of CUR still severely limit its application. Here, by …

Aim: To prepare a novel hybrid system for the controlled release and delivery of curcumin
(CUR). Methods: A method for the ultrasound-assisted fabrication of protein-modified …

Curcumin loaded ZnO nanoparticles were successfully synthesised and encapsulated with
co-polymer PMMA-AA (Cur/PMMA-AA/ZnO NPs). The ZnO nanoparticles have been …

Osteosarcoma is the most frequent primary malignant form of bone cancer, comprising 30%
of all bone cancer cases. The objective of this in vitro study was to develop a treatment …

Background Cancer is a group of diseases involving an abnormal growth of cells which tend
to proliferate in an uncontrolled fashion and in some cases metastasize to the surrounding …

Owing to great anticancer activity and excellent biosafety, curcumin (Cur) has potential
development in cancer therapy. Nevertheless, the anticancer activity of Cur is limited by the …

Curcumin (Cur) is a striking anticancer agent, but its low aqueous solubility, poor absorption,
hasty metabolism, and elimination limit its oral bioavailability and consequently hinder its …

Aim This study aimed to synthesise quercetin-caffeic-acid phenethyl ester (CAPE)-co-loaded
poly (lactic-co-glycolic-acid)(PLGA) nanoparticles (QuCaNP) and investigate their anti …